Health · Full coverage
FDA Approval Opens New Treatment Path for Type 1 Diabetes in Children
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
100% center
Center 2
First reported by N12 · Jun 25, 2026
What happened
The FDA has approved Tzield for children and teenagers already diagnosed with type 1 diabetes, aiming to slow pancreatic damage and preserve insulin production. Schneider Children’s Medical Center says the treatment could soon reach Israeli patients, but it is not yet in the health basket and is very expensive.
- 01FDA approved Tzield for diagnosed type 1 diabetes in ages 8 to 17.
- 02The drug aims to slow pancreatic damage, not cure diabetes.
- 03Schneider says Israeli children may soon benefit from the treatment.
- 04ADIR uses blood tests to estimate risk with about 85% accuracy.
- 05The drug costs about 500,000 shekels per treatment, and may need two.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Innovative Gene Therapy Enables Kidney-Only Transplant for Israeli Toddler with Rare Genetic DiseaseJul 13, 2026Teva Advances Potential Breakthrough Drug for Tourette Syndrome in Children6 days agoIsraeli Breakthrough in Oral Immunotherapy Offers Hope for Life-Threatening Food AllergiesJul 16, 2026FDA Approves New ADHD Drug Simtriyo for Children and Adults with Early Symptom ImprovementAug 2, 2026Experts Advise Caution and Holistic Approach for New ADHD Medication in ChildrenAug 6, 2026Shaare Zedek Introduces Revolutionary Treatment for Complex Vascular Malformations in ChildrenJun 28, 2026
